CytoMed Therapeutics Statistics

Total Valuation

GDTC has a market cap or net worth of $29.54 million. The enterprise value is $24.83 million.

Market Cap	29.54M
Enterprise Value	24.83M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

GDTC has 11.54 million shares outstanding. The number of shares has increased by 29.10% in one year.

Current Share Class	11.54M
Shares Outstanding	11.54M
Shares Change (YoY)	+29.10%
Shares Change (QoQ)	-0.01%
Owned by Insiders (%)	18.79%
Owned by Institutions (%)	0.04%
Float	3.55M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	89.46
Forward PS	55.70
PB Ratio	3.94
P/TBV Ratio	3.95
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	75.17
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 21.53, with a Debt / Equity ratio of 0.04.

Current Ratio	21.53
Quick Ratio	19.20
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-170.36

Financial Efficiency

Return on equity (ROE) is -26.26% and return on invested capital (ROIC) is -17.87%.

Return on Equity (ROE)	-26.26%
Return on Assets (ROA)	-17.44%
Return on Capital (ROIC)	-17.87%
Revenue Per Employee	$11,795
Profits Per Employee	-$80,701
Employee Count	28
Asset Turnover	0.04
Inventory Turnover	n/a

Taxes

In the past 12 months, GDTC has paid $482 in taxes.

Income Tax	482
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -34.53% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-34.53%
50-Day Moving Average	2.43
200-Day Moving Average	2.06
Relative Strength Index (RSI)	51.57
Average Volume (20 Days)	26,648

Short Selling Information

The latest short interest is 75,557, so 0.65% of the outstanding shares have been sold short.

Short Interest	75,557
Short Previous Month	76,802
Short % of Shares Out	0.65%
Short % of Float	2.13%
Short Ratio (days to cover)	4.21

Income Statement

In the last 12 months, GDTC had revenue of $330,254 and -$2.26 million in losses. Loss per share was -$0.20.

Revenue	330,254
Gross Profit	330,372
Operating Income	-2.55M
Pretax Income	-3.12M
Net Income	-2.26M
EBITDA	-2.30M
EBIT	-2.55M
Loss Per Share	-$0.20

Full Income Statement

Balance Sheet

The company has $5.03 million in cash and $315,935 in debt, giving a net cash position of $4.72 million or $0.41 per share.

Cash & Cash Equivalents	5.03M
Total Debt	315,935
Net Cash	4.72M
Net Cash Per Share	$0.41
Equity (Book Value)	7.50M
Book Value Per Share	0.65
Working Capital	5.42M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$1.88 million and capital expenditures -$701,736, giving a free cash flow of -$2.59 million.

Operating Cash Flow	-1.88M
Capital Expenditures	-701,736
Free Cash Flow	-2.59M
FCF Per Share	-$0.22

Full Cash Flow Statement

Margins

Gross Margin	100.04%
Operating Margin	-773.56%
Pretax Margin	-684.13%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

GDTC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-29.10%
Shareholder Yield	-29.10%
Earnings Yield	-7.65%
FCF Yield	-8.76%

Analyst Forecast

The average price target for GDTC is $5.00, which is 95.31% higher than the current price. The consensus rating is "Buy".

Price Target	$5.00
Price Target Difference	95.31%
Analyst Consensus	Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

GDTC has an Altman Z-Score of 37.35 and a Piotroski F-Score of 2.

Altman Z-Score	37.35
Piotroski F-Score	2